Introduction
Introduction
The single most important prognostic indicator in breast cancer patients is the presence of metastatic dissemination to axillary lymph nodes [1] . The sentinel lymph node (SLN) is the lymph node that primarily drains the tumour site and SLN biopsy (SLNB) is considered the standard of care for clinically nodenegative disease [2] . However, the role and utility of high throughput evaluation of SLNs and the finding of minimal metastases continue to fuel debate. The pathological assessment of the SLNs with multilevel evaluation and immunohistochemistry (IHC) is common practice [3] and isolated tumour cells (ITCs) have been separated from micrometastases in international staging manuals for breast cancer [4] . However, recent studies with up to 6 years of follow-up have demonstrated that both patients with negative SLN and patients with SLN micrometastases had low recurrence of axillary metastases and they report no statistical differences in overall survival between patients with negative SLN and SLN micrometastases [5, 6] . The upstaging potential of SLNB and the workload imposed by a systematic search for lowvolume SLN involvement has stimulated pathologists to move toward establishing alternative procedures such as RT-PCR to detect minimal amounts of mRNAs of specific breast cancer markers [7] [8] [9] [10] [11] [12] [13] . The majority of the studies [7, 10, 12, 13] [14, 15] 
have compared RT-PCR analysis of fresh nodal tissues with H&E and IHC analysis of formalin-fixed paraffin embedded SLNs. Few studies

Results
The mRNA extraction from fixed tissue was successful only in 93% of cases, corresponding to 69 SLNs from 58 patients. The total RNA extracted from each SLN varied from 4 to 140 g (see Fig. 2 ). Clinical-pathological characteristics of these 58 patients are detailed in Table 1 By (Fig. 1B) (Fig. 1D) . Analogously, RT-PCR Present 17 (Fig. 3) . Table 5 .
8%) SLNs were positive for at least one gene with RT-PCR performed on sections obtained from between levels 4 and 5 (Table 3). Specifically, 6 out of 7 cases positive for metastases and 1 out of 2 micrometastases were RT-PCR positive with all three markers. The specificity of this kind of positivity was indirectly shown by the negative results of RT-PCR performed on sections obtained in early levels of the SLN affected by macrometastases in the last 7 levels of sectioning (Table 4, case 10, Fig. 1C). The sections collected for IHC analysis of these last levels were thus used for RT-PCR and this time the tissue was positive for all 3 markers
*9 cases with macro-and micro-metastases in SLN, 2 cases with ITC and in 2 cases with negative SLN (pN0(iϪ)). performed on tissue obtained between levels 4 and 5 was negative for 3 markers in one SLN affected by a micrometastases detected by H&E staining of sections from levels 1 through 4 (
Axillary dissection was completed in the 9 cases of SLNs with macro and micro-metastases and in 2 cases with SLNs with ITC.
Axillary dissection was performed also in 2 cases with negative SLN due to the high-grade of the primary tumour in one case and to the presence of lymphovascular invasion in the other. The histological analysis of the axillary dissection suggested a correlation of non-SLN metastases with the presence of lymphovascular invasion; the positive results of the RT-PCR are shown in
Discussion
It is commonly reported that the discrepancy between the results of RT-PCR and immuno-morphological analysis in the study of SLN from breast cancer depends on the gross sampling procedure [15] . The majority of protocols use half of the unfixed lymph node for molecular analysis and the other half as fixed samples for traditional immuno-morphology [12, 13, 26] . Using methacarn for fixation to preserve both morphology and high quality mRNA [21, 22] Previous studies utilizing epithelial mRNA markers to detect breast cancer micrometastases by RT-PCR [7-11, 14, 26] have outlined the risk of false-positive results, whereas tumour mRNA markers are more specific, but are not uniformly expressed in all 1, 2, 3, 4, 6, 7, 8) [12] .
Fig. 3 RT-PCR analysis of Mammaglobin in FFPE primary tumours corresponding to SLNs with ITC (cases
Recently, new assays for quantitative measurement of Mammoglobin and/or CK19 expression [33] [34] [35] 
